Pushing the Pedal to the Metal: Should We Accelerate Infliximab Therapy for Patients With Severe Ulcerative Colitis?

被引:31
作者
Herfarth, Hans H. [1 ]
Rogler, Gerhard [2 ]
机构
[1] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC 27514 USA
[2] Univ Zurich, Div Gastroenterol & Hepatol, Zurich, Switzerland
关键词
METAANALYSIS; INDUCTION; COLECTOMY; PARALLEL;
D O I
10.1016/j.cgh.2014.09.045
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:336 / 338
页数:3
相关论文
共 22 条
  • [1] Adedokun O.J., 2014, GASTROENTEROLOGY
  • [2] Brandse JF, 2013, GASTROENTEROLOGY, V144, pS36
  • [3] CasteeleNV GilsA, 2013, Inflammatory bowel diseases, V19, pS2
  • [4] Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Publication with Expression of Concern)
    Dignass, Axel
    Lindsay, James O.
    Sturm, Andreas
    Windsor, Alastair
    Colombel, Jean-Frederic
    Allez, Mathieu
    D'Haens, Gert
    D'Hoore, Andre
    Mantzaris, Gerassimos
    Novacek, Gottfried
    Oeresland, Tom
    Reinisch, Walter
    Sans, Miquel
    Stange, Eduard
    Vermeire, Severine
    Travis, Simon
    Van Assche, Gert
    [J]. JOURNAL OF CROHNS & COLITIS, 2012, 6 (10) : 991 - 1030
  • [5] Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
    Fasanmade, Adedigbo A.
    Adedokun, Omoniyi J.
    Ford, Joyce
    Hernandez, Danika
    Johanns, Jewel
    Hu, Chuanpu
    Davis, Hugh M.
    Zhou, Honghui
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (12) : 1211 - 1228
  • [6] An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis
    Gibson, David J.
    Heetun, Zaid S.
    Redmond, Ciaran E.
    Nanda, Kavin S.
    Keegan, Denise
    Byrne, Kathryn
    Mulcahy, Hugh E.
    Cullen, Garret
    Doherty, Glen A.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (02) : 330 - U170
  • [7] Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study
    Järnerot, G
    Hertervig, E
    Friis-Liby, I
    Blomquist, L
    Karlé, P
    Grännö, C
    Vilien, M
    Ström, M
    Danielsson, Å
    Verbaan, H
    Hellström, PM
    Magnuson, A
    Curman, B
    [J]. GASTROENTEROLOGY, 2005, 128 (07) : 1805 - 1811
  • [8] Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
    Khanna, R.
    Sattin, B. D.
    Afif, W.
    Benchimol, E. I.
    Bernard, E. -J.
    Bitton, A.
    Bressler, B.
    Fedorak, R. N.
    Ghosh, S.
    Greenberg, G. R.
    Marshall, J. K.
    Panaccione, R.
    Seidman, E. G.
    Silverberg, M. S.
    Steinhart, A. H.
    Sy, R.
    Van Assche, G.
    Walters, T. D.
    Sandborn, W. J.
    Feagan, B. G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (05) : 447 - 459
  • [9] Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727
  • [10] Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
    Laharie, David
    Bourreille, Arnaud
    Branche, Julien
    Allez, Matthieu
    Bouhnik, Yoram
    Filippi, Jerome
    Zerbib, Frank
    Savoye, Guillaume
    Nachury, Maria
    Moreau, Jacques
    Delchier, Jean-Charles
    Cosnes, Jacques
    Ricart, Elena
    Dewit, Olivier
    Lopez-Sanroman, Antonio
    Dupas, Jean-Louis
    Carbonnel, Franck
    Bommelaer, Gilles
    Coffin, Benoit
    Roblin, Xavier
    Van Assche, Gert
    Esteve, Maria
    Farkkila, Martti
    Gisbert, Javier P.
    Marteau, Philippe
    Nahon, Stephane
    de Vos, Martine
    Franchimont, Denis
    Mary, Jean-Yves
    Colombel, Jean-Frederic
    Lemann, Marc
    [J]. LANCET, 2012, 380 (9857) : 1909 - 1915